 | • レポートコード：GIR-105X01017 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、駆虫薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。駆虫薬の種類別市場規模（経口薬、注射剤）、用途別市場規模（ヒト用、動物用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・駆虫薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Pfizer、Bayer、Cipla、Sun Pharmaceutical Industries、Mankind Pharma、Johnson & Johnson、Merck ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口薬、注射剤 ・用途別分析2016年-2026年：ヒト用、動物用 ・駆虫薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・駆虫薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・駆虫薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・駆虫薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・駆虫薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anthelmintic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anthelmintic Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Anthelmintic Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Anthelmintic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Drugs
Injectables
Market segment by Application can be divided into
For Human
For Animal
The key market players for global Anthelmintic Drugs market are listed below:
Novartis
Pfizer
Bayer
Cipla
Sun Pharmaceutical Industries
Mankind Pharma
Johnson & Johnson
Merck
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Anthelmintic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anthelmintic Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral Drugs
1.2.3 Injectables
1.3 Market Analysis by Application
1.3.1 Overview: Global Anthelmintic Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 For Human
1.3.3 For Animal
1.4 Global Anthelmintic Drugs Market Size & Forecast
1.4.1 Global Anthelmintic Drugs Sales in Value (2016-2026))
1.4.2 Global Anthelmintic Drugs Sales in Volume (2016-2026)
1.4.3 Global Anthelmintic Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Anthelmintic Drugs Production Capacity Analysis
1.5.1 Global Anthelmintic Drugs Total Production Capacity (2016-2026)
1.5.2 Global Anthelmintic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anthelmintic Drugs Market Drivers
1.6.2 Anthelmintic Drugs Market Restraints
1.6.3 Anthelmintic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Anthelmintic Drugs Product and Services
2.1.4 Novartis Anthelmintic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Anthelmintic Drugs Product and Services
2.2.4 Pfizer Anthelmintic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Anthelmintic Drugs Product and Services
2.3.4 Bayer Anthelmintic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Anthelmintic Drugs Product and Services
2.4.4 Cipla Anthelmintic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sun Pharmaceutical Industries
2.5.1 Sun Pharmaceutical Industries Details
2.5.2 Sun Pharmaceutical Industries Major Business
2.5.3 Sun Pharmaceutical Industries Anthelmintic Drugs Product and Services
2.5.4 Sun Pharmaceutical Industries Anthelmintic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Mankind Pharma
2.6.1 Mankind Pharma Details
2.6.2 Mankind Pharma Major Business
2.6.3 Mankind Pharma Anthelmintic Drugs Product and Services
2.6.4 Mankind Pharma Anthelmintic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Anthelmintic Drugs Product and Services
2.7.4 Johnson & Johnson Anthelmintic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Anthelmintic Drugs Product and Services
2.8.4 Merck Anthelmintic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Anthelmintic Drugs Sales by Manufacturer
3.1 Global Anthelmintic Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anthelmintic Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anthelmintic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anthelmintic Drugs Manufacturer Market Share
3.4.2 Top 6 Anthelmintic Drugs Manufacturer Market Share
3.5 Global Anthelmintic Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anthelmintic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anthelmintic Drugs Market Size by Region
4.1.1 Global Anthelmintic Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Anthelmintic Drugs Revenue by Region (2016-2026)
4.2 North America Anthelmintic Drugs Revenue (2016-2026)
4.3 Europe Anthelmintic Drugs Revenue (2016-2026)
4.4 Asia-Pacific Anthelmintic Drugs Revenue (2016-2026)
4.5 South America Anthelmintic Drugs Revenue (2016-2026)
4.6 Middle East and Africa Anthelmintic Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anthelmintic Drugs Sales in Volume by Type (2016-2026)
5.2 Global Anthelmintic Drugs Revenue by Type (2016-2026)
5.3 Global Anthelmintic Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anthelmintic Drugs Sales in Volume by Application (2016-2026)
6.2 Global Anthelmintic Drugs Revenue by Application (2016-2026)
6.3 Global Anthelmintic Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anthelmintic Drugs Sales by Type (2016-2026)
7.2 North America Anthelmintic Drugs Sales by Application (2016-2026)
7.3 North America Anthelmintic Drugs Market Size by Country
7.3.1 North America Anthelmintic Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Anthelmintic Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anthelmintic Drugs Sales by Type (2016-2026)
8.2 Europe Anthelmintic Drugs Sales by Application (2016-2026)
8.3 Europe Anthelmintic Drugs Market Size by Country
8.3.1 Europe Anthelmintic Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Anthelmintic Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anthelmintic Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Anthelmintic Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Anthelmintic Drugs Market Size by Region
9.3.1 Asia-Pacific Anthelmintic Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anthelmintic Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anthelmintic Drugs Sales by Type (2016-2026)
10.2 South America Anthelmintic Drugs Sales by Application (2016-2026)
10.3 South America Anthelmintic Drugs Market Size by Country
10.3.1 South America Anthelmintic Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Anthelmintic Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anthelmintic Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Anthelmintic Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Anthelmintic Drugs Market Size by Country
11.3.1 Middle East & Africa Anthelmintic Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anthelmintic Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anthelmintic Drugs Typical Distributors
12.3 Anthelmintic Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anthelmintic Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anthelmintic Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Anthelmintic Drugs Product and Services
Table 6. Novartis Anthelmintic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Anthelmintic Drugs Product and Services
Table 10. Pfizer Anthelmintic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Anthelmintic Drugs Product and Services
Table 14. Bayer Anthelmintic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cipla Basic Information, Manufacturing Base and Competitors
Table 16. Cipla Major Business
Table 17. Cipla Anthelmintic Drugs Product and Services
Table 18. Cipla Anthelmintic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 20. Sun Pharmaceutical Industries Major Business
Table 21. Sun Pharmaceutical Industries Anthelmintic Drugs Product and Services
Table 22. Sun Pharmaceutical Industries Anthelmintic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Mankind Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Mankind Pharma Major Business
Table 25. Mankind Pharma Anthelmintic Drugs Product and Services
Table 26. Mankind Pharma Anthelmintic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 28. Johnson & Johnson Major Business
Table 29. Johnson & Johnson Anthelmintic Drugs Product and Services
Table 30. Johnson & Johnson Anthelmintic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merck Basic Information, Manufacturing Base and Competitors
Table 32. Merck Major Business
Table 33. Merck Anthelmintic Drugs Product and Services
Table 34. Merck Anthelmintic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Anthelmintic Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 36. Global Anthelmintic Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Anthelmintic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Anthelmintic Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Anthelmintic Drugs Production Site of Key Manufacturer
Table 40. Global Anthelmintic Drugs Sales by Region (2016-2021e) & (K Units)
Table 41. Global Anthelmintic Drugs Sales by Region (2021-2026) & (K Units)
Table 42. Global Anthelmintic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Anthelmintic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Anthelmintic Drugs Sales by Type (2016-2021e) & (K Units)
Table 45. Global Anthelmintic Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Global Anthelmintic Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Anthelmintic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Anthelmintic Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 49. Global Anthelmintic Drugs Price by Type (2021-2026) & (USD/Unit)
Table 50. Global Anthelmintic Drugs Sales by Application (2016-2021e) & (K Units)
Table 51. Global Anthelmintic Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Global Anthelmintic Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Anthelmintic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Anthelmintic Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 55. Global Anthelmintic Drugs Price by Application (2021-2026) & (USD/Unit)
Table 56. North America Anthelmintic Drugs Sales by Country (2016-2021e) & (K Units)
Table 57. North America Anthelmintic Drugs Sales by Country (2021-2026) & (K Units)
Table 58. North America Anthelmintic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Anthelmintic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Anthelmintic Drugs Sales by Type (2016-2021e) & (K Units)
Table 61. North America Anthelmintic Drugs Sales by Type (2021-2026) & (K Units)
Table 62. North America Anthelmintic Drugs Sales by Application (2016-2021e) & (K Units)
Table 63. North America Anthelmintic Drugs Sales by Application (2021-2026) & (K Units)
Table 64. Europe Anthelmintic Drugs Sales by Country (2016-2021e) & (K Units)
Table 65. Europe Anthelmintic Drugs Sales by Country (2021-2026) & (K Units)
Table 66. Europe Anthelmintic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Anthelmintic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Anthelmintic Drugs Sales by Type (2016-2021e) & (K Units)
Table 69. Europe Anthelmintic Drugs Sales by Type (2021-2026) & (K Units)
Table 70. Europe Anthelmintic Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. Europe Anthelmintic Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Asia-Pacific Anthelmintic Drugs Sales by Region (2016-2021e) & (K Units)
Table 73. Asia-Pacific Anthelmintic Drugs Sales by Region (2021-2026) & (K Units)
Table 74. Asia-Pacific Anthelmintic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Anthelmintic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Anthelmintic Drugs Sales by Type (2016-2021e) & (K Units)
Table 77. Asia-Pacific Anthelmintic Drugs Sales by Type (2021-2026) & (K Units)
Table 78. Asia-Pacific Anthelmintic Drugs Sales by Application (2016-2021e) & (K Units)
Table 79. Asia-Pacific Anthelmintic Drugs Sales by Application (2021-2026) & (K Units)
Table 80. South America Anthelmintic Drugs Sales by Country (2016-2021e) & (K Units)
Table 81. South America Anthelmintic Drugs Sales by Country (2021-2026) & (K Units)
Table 82. South America Anthelmintic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Anthelmintic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Anthelmintic Drugs Sales by Type (2016-2021e) & (K Units)
Table 85. South America Anthelmintic Drugs Sales by Type (2021-2026) & (K Units)
Table 86. South America Anthelmintic Drugs Sales by Application (2016-2021e) & (K Units)
Table 87. South America Anthelmintic Drugs Sales by Application (2021-2026) & (K Units)
Table 88. Middle East & Africa Anthelmintic Drugs Sales by Country (2016-2021e) & (K Units)
Table 89. Middle East & Africa Anthelmintic Drugs Sales by Country (2021-2026) & (K Units)
Table 90. Middle East & Africa Anthelmintic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Anthelmintic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Anthelmintic Drugs Sales by Type (2016-2021e) & (K Units)
Table 93. Middle East & Africa Anthelmintic Drugs Sales by Type (2021-2026) & (K Units)
Table 94. Middle East & Africa Anthelmintic Drugs Sales by Application (2016-2021e) & (K Units)
Table 95. Middle East & Africa Anthelmintic Drugs Sales by Application (2021-2026) & (K Units)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Anthelmintic Drugs Typical Distributors
Table 99. Anthelmintic Drugs Typical Customers
List of Figures
Figure 1. Anthelmintic Drugs Picture
Figure 2. Global Anthelmintic Drugs Sales Market Share by Type in 2020
Figure 3. Oral Drugs
Figure 4. Injectables
Figure 5. Global Anthelmintic Drugs Sales Market Share by Application in 2020
Figure 6. For Human
Figure 7. For Animal
Figure 8. Global Anthelmintic Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Anthelmintic Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Anthelmintic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Anthelmintic Drugs Sales (2016-2026) & (K Units)
Figure 30. Global Anthelmintic Drugs Production Capacity (2016-2026) & (K Units)
Figure 31. Global Anthelmintic Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Anthelmintic Drugs Market Drivers
Figure 33. Anthelmintic Drugs Market Restraints
Figure 34. Anthelmintic Drugs Market Trends
Figure 35. Global Anthelmintic Drugs Sales Market Share by Manufacturer in 2020
Figure 36. Global Anthelmintic Drugs Revenue Market Share by Manufacturer in 2020
Figure 37. Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Anthelmintic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Anthelmintic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Anthelmintic Drugs Sales Market Share by Region (2016-2026)
Figure 41. Global Anthelmintic Drugs Revenue Market Share by Region (2016-2026)
Figure 42. North America Anthelmintic Drugs Revenue (2016-2026) & (USD Million)
Figure 43. Europe Anthelmintic Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Anthelmintic Drugs Revenue (2016-2026) & (USD Million)
Figure 45. South America Anthelmintic Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Anthelmintic Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Global Anthelmintic Drugs Sales Market Share by Type (2016-2026)
Figure 48. Global Anthelmintic Drugs Revenue Market Share by Type (2016-2026)
Figure 49. Global Anthelmintic Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Anthelmintic Drugs Sales Market Share by Application (2016-2026)
Figure 51. Global Anthelmintic Drugs Revenue Market Share by Application (2016-2026)
Figure 52. Global Anthelmintic Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Anthelmintic Drugs Sales Market Share by Country (2016-2026)
Figure 54. North America Anthelmintic Drugs Revenue Market Share by Country (2016-2026)
Figure 55. North America Anthelmintic Drugs Sales Market Share by Type (2016-2026)
Figure 56. North America Anthelmintic Drugs Sales Market Share by Application (2016-2026)
Figure 57. Europe Anthelmintic Drugs Sales Market Share by Country (2016-2026)
Figure 58. Europe Anthelmintic Drugs Revenue Market Share by Country (2016-2026)
Figure 59. Europe Anthelmintic Drugs Sales Market Share by Type (2016-2026)
Figure 60. Europe Anthelmintic Drugs Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Anthelmintic Drugs Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Anthelmintic Drugs Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Anthelmintic Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Anthelmintic Drugs Sales Market Share by Application (2016-2026)
Figure 65. South America Anthelmintic Drugs Sales Market Share by Country (2016-2026)
Figure 66. South America Anthelmintic Drugs Revenue Market Share by Country (2016-2026)
Figure 67. South America Anthelmintic Drugs Sales Market Share by Type (2016-2026)
Figure 68. South America Anthelmintic Drugs Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Anthelmintic Drugs Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Anthelmintic Drugs Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Anthelmintic Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Anthelmintic Drugs Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
メトトレキサート薬口径薬の世界市場2018-2025 Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions.In 2018, the global Methotrexate Oral Solution Drugs market size was xx million US$ and is forec…- メルカプトプリン経口液剤の世界市場2018-2025 Mercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine. In 2018, the global Mercaptopurine Oral Solution Drugs market size was xx million US$ and is forecast to xx million US in 202…
- 世界の新規経口抗凝固薬市場 2021：企業別、地域別、種類・用途別 The Novel Oral Anticoagulants Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界の動物用処方薬市場 2021：企業別、地域別、種類・用途別 The Animal Prescription Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- トレチノイン薬の世界市場2018-2025 Tretinoin is medication used for the treatment of acne and acute promyelocytic leukemia. For acne, it is applied to the skin as a cream or ointment. For leukemia, it is taken by mouth for up to three months.In 2018, the global Tretinoin Drugs market size was xx million US$ and is forecast to xx mill…